Investor
This new funding round brings the company's total raise to roughly $62.5 million.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
The industrial giant plans to retain a stake of almost 20% in GE Healthcare.
The new funding round brings the company's valuation to $4.6 billion.
The company said the latest round brings its total raise to $47 million.
This IPO comes roughly a year after the company closed a $25 million SPAC.
The company will cater to individuals with serious mental illness and severe depression.
Nanox also completed the acquisition of USARAD Holdings and its affiliated company, MDWEB.
Also: Pediatric sleep app Huckleberry raises $12.5 million, and illumigyn, maker of a platform for remote gynecological imaging, brings in $33 million.
COVID-19 has changed the healthcare workforce, but automation could be the future.